← SynDRA
ERGOCALCIFEROL
SynDRA canonical compound SYN0008965 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | VDR |
| Mechanism of action | vitamin analog |
| Indication | hypoparathyroidism | hypophosphatemia | rickets |
| Disease area | endocrinology | orthopedics |
All known targets
Mechanisms of action (all sources)
- VDR AGONIST
- Vitamin D receptor agonist
- VDR ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ABCB11
- MAPK1
- OPRD1
- NR3C1
- NPY2R
- NPY1R
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAOA
- HDAC6
- LCK
- KDM4A
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- OPRK1
- OPRM1
- PDE3A
- SLC6A4
- UGT2B7
- UGT1A4
- UGT1A1
- TST
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Micronutrients
- Vitamins
- Provitamin D2 Compound
- vitamin analog
ATC classes
- A11C · VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
Cross-references
Synonyms
- BEROCCA PN
- DELTALIN
- DRISDOL
- Doral
- Drisdol
- M.V.C. 9+3
- M.V.I. ADULT
- M.V.I. ADULT (PHARMACY BULK PACKAGE)
- M.V.I. PEDIATRIC
- M.V.I.-12 ADULT
- M.V.I.-12 LYOPHILIZED
- vitamin D2
- calciferol
- ercalciol
- ergorone
- Vitamin d2
- Calciferol
- Ergocalciferolum
- Ergorone
- Ostelin
- Viosterol
- Vitamin d
- Vitamin d (ergocalciferol)
- Vitamin d nos
- Vitamin d, unspecified form
- NSC-62792
- Deltalin
- Eciferol d2
- Ergo-d2
- Ergocalciferol component of vitaped
- Ergoral d2
- Sterogyl
- Sterogyl 15h
- Sterogyl-15
- Uvesterol d
- Vitamin d 2
- Calciferolum
Reported adverse events
- Nausea
- Hypervitaminosis D
Look up ERGOCALCIFEROL in the interactive SynDRA portal →